UNICA IRIS Institutional Research Information System

CORONA, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 270.989
NA - Nord America 10.517
AS - Asia 5.154
SA - Sud America 819
AF - Africa 185
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 287.687
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 268.136
US - Stati Uniti d'America 10.353
SG - Singapore 2.024
CN - Cina 1.690
SE - Svezia 684
BR - Brasile 615
UA - Ucraina 502
VN - Vietnam 486
DE - Germania 365
FI - Finlandia 308
FR - Francia 244
GB - Regno Unito 236
HK - Hong Kong 179
IN - India 146
BY - Bielorussia 120
CA - Canada 94
KR - Corea 93
AR - Argentina 88
NL - Olanda 79
BD - Bangladesh 67
AT - Austria 62
MA - Marocco 61
JP - Giappone 60
IQ - Iraq 55
PK - Pakistan 54
MX - Messico 50
ZA - Sudafrica 42
PL - Polonia 40
TR - Turchia 39
RU - Federazione Russa 37
ES - Italia 33
ID - Indonesia 32
IR - Iran 31
BE - Belgio 30
SA - Arabia Saudita 30
EC - Ecuador 29
CO - Colombia 26
IE - Irlanda 21
UZ - Uzbekistan 20
VE - Venezuela 20
KE - Kenya 16
PH - Filippine 16
TN - Tunisia 16
EG - Egitto 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
IL - Israele 13
JO - Giordania 13
TW - Taiwan 13
AZ - Azerbaigian 12
NP - Nepal 12
AU - Australia 11
CL - Cile 11
MY - Malesia 11
DK - Danimarca 10
BO - Bolivia 9
ET - Etiopia 9
DZ - Algeria 8
GE - Georgia 8
LV - Lettonia 8
UY - Uruguay 8
AL - Albania 7
CH - Svizzera 7
EU - Europa 7
LT - Lituania 7
HU - Ungheria 6
KG - Kirghizistan 6
NO - Norvegia 6
PT - Portogallo 6
PY - Paraguay 6
GR - Grecia 5
NI - Nicaragua 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
DO - Repubblica Dominicana 3
LB - Libano 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
OM - Oman 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
A1 - Anonimo 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
RS - Serbia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
Totale 287.661
Salva come PNG Salva come JPEG
Città #
Cagliari 260.921
Uta 6.195
Singapore 1.101
Ashburn 1.066
Fairfield 842
Woodbridge 702
San Jose 639
Chandler 560
Dallas 547
Nyköping 431
Houston 411
Boardman 404
Seattle 362
Wilmington 345
Beijing 342
Ann Arbor 313
Cambridge 280
Los Angeles 243
New York 229
Jacksonville 225
Helsinki 207
Council Bluffs 196
Dearborn 190
Santa Clara 160
Hong Kong 156
Shanghai 155
The Dalles 150
Ho Chi Minh City 141
Lauterbourg 134
Hefei 117
Boston 110
Nanjing 109
Dong Ket 98
Hanoi 84
Seoul 81
Chicago 75
Rome 67
San Diego 65
Buffalo 63
Munich 61
Redwood City 61
Milan 55
São Paulo 54
Herndon 47
Casablanca 44
Tokyo 44
Vienna 42
Guangzhou 40
Amsterdam 38
Hangzhou 38
Redondo Beach 37
Changsha 36
Orem 36
London 35
Frankfurt am Main 34
Tianjin 34
Toronto 33
Mountain View 32
Sassari 32
Phoenix 31
Atlanta 29
Nanchang 29
Rio de Janeiro 29
Washington 29
Shenyang 28
Warsaw 28
Verona 27
Redmond 26
Salt Lake City 26
Chennai 25
Nuremberg 24
Jiaxing 23
Brooklyn 22
Hebei 22
Lappeenranta 22
Johannesburg 21
Brussels 20
Mumbai 20
Denver 19
Dublin 19
San Francisco 19
Tashkent 19
Baghdad 18
Montreal 18
Norwalk 18
Columbus 16
Gujranwala 16
Manchester 16
Mexico City 16
Ottawa 16
Curitiba 15
Lahore 15
Wuhan 15
Zhengzhou 15
Des Moines 14
Dhaka 14
Jinan 14
Nairobi 14
Pittsburgh 14
Stockholm 14
Totale 280.184
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.721
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.057
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.679
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.522
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.465
Biological activities of aerial parts extracts of Euphorbia characias 4.439
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.329
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.184
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.744
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.514
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.457
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.442
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.432
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.412
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.371
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.337
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.309
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.306
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.295
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.274
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.200
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.101
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.086
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.073
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.049
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 3.043
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.035
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 2.999
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 2.987
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.970
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.928
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.920
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.909
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.891
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.885
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.878
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.872
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.859
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.830
Insights into Ebola VP35 oligomerization from molecular simulations 2.816
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.785
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.770
null 2.746
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.728
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.708
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.634
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.630
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.612
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.566
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.457
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.431
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.422
An efficient route to novel uracil-based drug-like molecules 2.368
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.354
null 2.329
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.305
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.260
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.257
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.226
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.149
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.137
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.130
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.107
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.102
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.075
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.069
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.061
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.968
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.881
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.878
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.873
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.869
Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H 1.828
null 1.820
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.796
The traditional Chinese medicine plant Schisandra Chinensis as source of new HIV-1 reverse transcriptase inhibitor scaffolds effective also on non-nucleoside resistant reverse transcriptases 1.792
New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function 1.719
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.705
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 1.681
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.628
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.611
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen 1.583
From classic to innovative approaches in HIV-1 infection treatment 1.557
Hypericum hircinum L. components as new single molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. 1.548
Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives 1.533
2-methoxynaphthalen thiazole derivate : a new HIV-1 RT Ribonuclease H/DNA polymerase dual inhibitor active on viral replication 1.519
Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2 1.449
Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development? 1.434
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules 1.425
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production 1.425
Peptides Mimicking the β7/β8 loop of HIV-1 Reverse Transcriptase p51 as “Hotspot-Targeted” Dimerization Inhibitors 1.417
5-arylaminouracil derivatives as potential dual-action agents 1.352
Natural and Nature-Derived Products Targeting Human Coronaviruses 1.302
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities 1.299
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation 1.275
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort 1.213
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.198
A combined cell based and site directed mutagenesis approach defines highly conserved residues involved in the selective inhibition of the HIV-1 ribonuclease H function by diketoacid derivatives 1.137
In Vitro Anti-HIV-1 Reverse Transcriptase and Integrase Properties of Punica granatum L. Leaves, Bark, and Peel Extracts and Their Main Compounds 1.119
The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry 1.046
Totale 261.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 344.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 344.905
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219.948 0 0 0 0 0 0 0 0 0 3.947 4.211 1.790
2021/202215.606 1.541 1.302 877 903 1.139 1.247 897 907 1.513 1.470 1.799 2.011
2022/202326.453 2.280 3.722 3.079 2.423 1.570 2.878 1.282 1.827 1.399 1.519 2.128 2.346
2023/202424.258 1.620 862 1.324 1.822 2.331 4.147 3.191 2.097 1.158 1.331 2.071 2.304
2024/202550.727 13.089 15.338 7.484 4.880 2.332 2.847 2.652 236 492 377 448 552
2025/202611.375 877 412 1.483 1.103 1.099 795 2.189 1.149 829 1.439 0 0
Totale 288.352